The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Open accessThe DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Abstract
Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the molecular mechanisms of T cell lineage commitment and function. In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues. We also discuss the emerging clinical data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 induces IL-6 and G-CSF, cytokines that promote myeloid-driven innate inflammation”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Gaffen et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways
Kim, J. S., Sklarz, T., Banks, L. B., Gohil, M., Waickman, A. T., Skuli, N., Krock, B. L., Luo, C. T., Hu, W., Pollizzi, K. N., et al. (2013) · Nature Immunology · doi:10.1038/ni.2607 · Cited by 85
RetractedMosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Self-citationHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Self-citationVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Research works printed but not linked: 1
- Ghoreschi K Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling Nature 467 967 971 20962846 PMC3108066 · DOI · Paper page
Cited by
Items 501–600 of 1,000
Inflammatory bowel disease in Korea: epidemiology and pathophysiology
Lee, J. W., & Eun, C. S. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.138 · Cited by 45
“Tregs can also upregulate RORγt, a transcription factor of Th17 and innate lymphoid cells, allowing the Treg subset to specifically suppress the type 17 immune response in the intestinal mucosa [75].”
BackgroundFreundt-Revilla, J., Maiolini, A., Carlson, R., Beyerbach, M., Rentmeister, K., Flegel, T., Fischer, A., & Tipold, A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0784-3 · Cited by 44
“Current medical trials aimed to neutralize IL-17 or IL23 have shown to be highly effective in humans in the treatment of psoriasis and show promising initial results in ankylosing spondylitis and multiple sclerosis [65].”
ResultThe genetics revolution in rheumatology: large scale genomic arrays and genetic mapping
Eyre, S., Orozco, G., & Worthington, J. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.80 · Cited by 46
Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design
Narjes, F., Xue, Y., von Berg, S., Malmberg, J., Llinàs, A., Olsson, R. I., Jirholt, J., Grindebacke, H., Leffler, A., Hossain, N., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00783 · Cited by 44
IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?
Baeten, D., & Adamopoulos, I. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.623874 · Cited by 44
Transcription factor-driven regulation of ILC1 and ILC3
Schroeder, J.-H., Howard, J. K., & Lord, G. M. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.04.009 · Cited by 44
Chen, Y., Gong, F., Li, Z.-J., Gong, Z., Zhou, Z. C., Ma, S., & Gao, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-07261-1 · Cited by 44
The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities
Mima, K., Hamada, T., Inamura, K., Baba, H., Ugai, T., & Ogino, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2269623 · Cited by 43
IL-23R is a senescence-linked circulating and tissue biomarker of aging
Carver, C. M., Rodriguez, S. L., Atkinson, E. J., Dosch, A. J., Asmussen, N. C., Gomez, P. T., Leitschuh, E. A., Espíndola‐Netto, J. M., Jeganathan, K. B., Whaley, M. G., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00752-7 · Cited by 43
“Mice with genomic deficit of IL-23R do not elicit T H 17 responses and are resistant to experimental autoimmune encephalomyelitis 45 , and Resource https://doi.org/10.1038/s43587-024-00752-7 IL-23R dysfunction is linked to susceptibility to several autoimmune diseases 46 .”
InfluentialRUNX3 and T-Bet in Immunopathogenesis of Ankylosing Spondylitis—Novel Targets for Therapy?
Vecellio, M. L., Cohen, C., Roberts, A. R., Wordsworth, P. B., & Kenna, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03132 · Cited by 44
Suleiman, A. A., Minocha, M., Khatri, A., Pang, Y., & Othman, A. A. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00759-z · Cited by 43
Harnessing the IL-21-BATF Pathway in the CD8+ T Cell Anti-Tumor Response
Topchyan, P., Xin, G., Chen, Y., Zheng, S., Burns, R., Shen, J., Kasmani, M. Y., Kudek, M. R., Yang, N., & Cui, W. (2021) · Cancers · doi:10.3390/cancers13061263 · Cited by 43
“Together, BATF and IRF4 function as pioneer transcription factors, remodeling the chromatin landscape [48].”
BackgroundMargaroni, M., Agallou, M., Kontonikola, K., Karidi, K., Kammona, O., Kiparissides, C. A., Gaitanaki, C., & Karagouni, E. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.05.018 · Cited by 43
Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia
Debnath, M., & Berk, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0309-1 · Cited by 43
Dedong, H., Zhu, F., Shi, J., Xiaowei, L., & Shaoyang, W. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.04.002 · Cited by 43
Systemic Psoriasis: From Molecular Mechanisms to Global Management Strategies
Prema, S. S., & Shanmugamprema, D. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09089-4 · Cited by 43
“Over the past decades, numerous genome-wide association studies (GWAS) and functional investigations have consistently highlighted the importance of this axis in driving disease pathology [96, 97].”
Zhu, Z., Otáhal, P., Wang, B., Jin, X., Laslett, L. L., Wluka, A. E., Antony, B., Han, W., Wang, X., Winzenberg, T. M., et al. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.10.024 · Cited by 42
“Thus, IL-6, IL-23 and IL-17 form a new axis through 2 Th-17 cells, which has an important role in autoimm unity and chronic 3 inflammation [16-19].”
BackgroundIL-17 in Renal Immunity and Autoimmunity
Biswas, P. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1801042 · Cited by 42
“The IL-17 family consists of six cytokines: IL-17A (IL-17), IL-17B, IL-17C, IL-17D, IL-17E (IL-25), and IL-17F (6, 7).”
InfluentialBATF2 prevents T-cell-mediated intestinal inflammation through regulation of the IL-23/IL-17 pathway
Kayama, H., Tani, H., Kitada, S., Opasawatchai, A., Okumura, R., Motooka, D., Nakamura, S., & Takeda, K. (2019) · International Immunology · doi:10.1093/intimm/dxz014 · Cited by 42
Li, Y., Yang, Y., Wang, J., Cai, P., Li, M., Tang, X., Tan, Y. C., Wang, Y., Zhang, F., Wen, X., et al. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00871-4 · Cited by 42
Núñez‐Sánchez, M. Á., Melgar, S., O'DONOGHUE, K., Martínez‐Sánchez, M. A., Fernández-Ruiz, V. E., Ferrer‐Gómez, M., Ruiz‐Alcaraz, A. J., & Ramos‐Molina, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158361 · Cited by 42
“The stimulation of these type 17 cells with IL-23 and other pro-inflammatory mediators, such as IL-1β, also contribute to the local mucosa inflammation, fulfilling an important role in CD perpetuation [33].”
BackgroundLiu, S., Zhang, Q., Chen, C., Ge, D., Qu, Y., Chen, R., Fan, Y.-M., Li, N., Tang, W. W., Zhang, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7296 · Cited by 42
“Human HeLa and 293-IL-17RA stable cells were treated with 2 μM AZD5363 (Selleck Chemicals, Inc.), 50 ng/ml insulin (Sigma Aldrich), and/or 20 ng/ml recombinant human IL-17A (R & D Systems) for 2 h. Mouse embryonic fibroblasts (MEFs) with wild-type Gsk3β+/+ or knockout Gsk3β-/- were treated with 20 ng/ml recombinant mo…”
BackgroundInfluentialZhang, C., Yan, K., Diao, Q., Guo, Q., Jin, H., Yang, S., Chen, X., Lei, T., Wu, J., Yu, H., et al. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2022.01.005 · Cited by 41
BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease
Ullrich, E., Abendroth, B., Rothamer, J., Huber, C., Büttner-Herold, M. J., Buchele, V., Vogler, T., Longerich, T., Zundler, S., Völkl, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci89242 · Cited by 41
“The identification of Th17 cells and the discovery that Th17 cell–directed therapeutic strategies are highly effective to attenuate tissue inflammation have revolutionized the concepts of the pathogenesis of immune-mediated diseases (26).”
BackgroundEcoeur, F., Weiss, J., Kaupmann, K., Hintermann, S., Orain, D., & Guntermann, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00577 · Cited by 41
“It is possible that Cpd A acts on CD8Tc17, ILC3 and γδ T-cells that express RORγt and contribute to tissue inflammation (1, 25).”
BackgroundPrete, R., García-González, N., Mattia, C. D., Corsetti, A., & Battista, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-73201-1 · Cited by 41
Liddle, J., Bénéton, V., Benson, M. A., Bingham, R. P., Bouillot, A., Boullay, A.-B., Brook, E. I., Cryan, J., Denis, A., Edgar, E. V., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.01.029 · Cited by 41
Crossing the boundaries: IL-23 and its role in linking inflammation of the skin, gut and joints
Łukasik, Z. M., Gracey, E., Venken, K., Ritchlin, C. T., & Elewaut, D. S. (2021) · Rheumatology · doi:10.1093/rheumatology/keab385 · Cited by 41
Distinct interferon‐gamma and interleukin‐9 expression in cutaneous and oral lichen planus
Weber, B., Schlapbach, C., Stuck, M., Simon, H., Borradori, L., Beltraminelli, H., & Simon, D. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13989 · Cited by 41
IL-24 Promotes Pseudomonas aeruginosa Keratitis in C57BL/6 Mouse Corneas
Ross, B. X., Gao, N., Cui, X., Standiford, T. J., Xu, J., & Yu, F. X. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602087 · Cited by 41
Aneurysmal subarachnoid hemorrhage lead to systemic upregulation of IL-23/IL-17 inflammatory axis
Chaudhry, S. R., Güresir, E., Vatter, H., Kinfe, T. M., Dietrich, D., Lamprecht, A., & Muhammad, S. (2017) · Cytokine · doi:10.1016/j.cyto.2017.05.025 · Cited by 41
Pellegrini, C., Orlandi, A., Costanza, G., Stefani, A. D., Piccioni, A., Cesare, A. D., Chiricozzi, A., Ferlosio, A., Peris, K., & Fargnoli, M. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183415 · Cited by 41
HIF-1α modulates sex-specific Th17/Treg responses during hepatic amoebiasis
Groneberg, M., Hoenow, S., Marggraff, C., Fehling, H., Metwally, N. G., Hansen, C. S., Bruchhaus, I., Tiegs, G., Sellau, J., & Lotter, H. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.020 · Cited by 40
Goepfert, A., Barske, C., Lehmann, S., Wirth, E., Willemsen, J., Gudjonsson, J. E., Ward, N. L., Sarkar, M. K., Hemmig, R., Kolbinger, F., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111489 · Cited by 40
“The IL-17 family of pro-inflammatory cytokines is an important player in both adaptive and innate immunity (Gaffen et al., 2014; Veldhoen, 2017).”
Joulia, R., Guerrero-Fonseca, I. M., Girbl, T., Coates, J. A., Stein, M., Vázquez-Martínez, L., Lynam, E. G., Whiteford, J. R., Schnoor, M., Voehringer, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34695-7 · Cited by 40
Aiello, A., Fard, S. N., & Goletti, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1244556 · Cited by 41
Wei, L., Liu, M., Xiong, H., & Peng, B. (2017) · International Endodontic Journal · doi:10.1111/iej.12871 · Cited by 40
Shukla, P., Mansoori, M. N., & Singh, D. R. (2018) · Bone · doi:10.1016/j.bone.2018.01.027 · Cited by 40
Paroli, A. F., Gonzalez, P. V., Díaz-Luján, C. M., Onofrio, L. I., Arocena, A. R., Cano, R. C., Silva, E. A. C., & Gea, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00913 · Cited by 40
“In concordance with this, CD4+ and CD8+ T cells produce IFN-γ that further activate phagocytic cells to promote parasite killing (25) .”
BackgroundIt Takes “Guts” to Cause Joint Inflammation: Role of Innate-Like T Cells
Mortier, C., Govindarajan, S., Venken, K., & Elewaut, D. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01489 · Cited by 40
The Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma
Ladjevac, N., Milovanović, M., Jevtović, A., Arsenijević, D., Stojanović, B., Stojanovic, M. D., Stojanović, B., Arsenijević, N., Arsenijević, A., & Milovanović, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129874 · Cited by 39
“The post-transcriptional regulation of mRNA by IL-17 is part of a self-reinforcing mechanism that potentiates IL-17 activity [86].”
BackgroundUnintended Immunological Consequences of Biologic Therapy
Henrickson, S. E., Ruffner, M. A., & Kwan, M. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0624-7 · Cited by 39
IL ‐17F regulates psoriasis‐associated genes through IκBζ
Bertelsen, T., Ljungberg, C., Kjellerup, R. B., Iversen, L., & Johansen, C. (2016) · Experimental Dermatology · doi:10.1111/exd.13182 · Cited by 39
Ibrahim, S., Girault, A., Ohresser, M. C. P., Lereclus, E., Paintaud, G., Lecomte, T., & Raoul, W. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.10.003 · Cited by 39
“Interleukin-17: A New Player in CRC Development Interleukin-17 Family: A Rapid Overview The IL-17 family is already well known.(12) Briefly, IL-17A, the most studied ligand of this family, is a proinflammatory cytokine that contributes to the pathogenesis of inflammatory and autoimmune diseases.”
BackgroundLi, H., Li, J., Zhang, X., Feng, C., Fan, C., Yang, X., Zhang, R., Zhu, F., Zhou, Y., Xu, Y., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113958 · Cited by 39
Sun, N., Xie, Q., Dang, Y., & Wang, Y. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02178 · Cited by 39
Gil‐Pulido, J., Amézaga, N., Jorgacevic, I., Manthey, H. D., Rösch, M., Brand, T., Cidlinsky, P., Schäfer, S., Beilhack, A., Saliba, A., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab359 · Cited by 39
Anti-TNF therapy and immunogenicity in inflammatory bowel diseases: a translational approach.
Genaro, L. M., Gomes, L. E. M., Franceschini, A. P. M. D. F., Ceccato, H. D., de Jesus, R. N., Lima, A. P., Nagasako, C. K., Fagundes, J. J., Ayrizono, M. D. L. S., & Leal, R. F. (2021) · PubMed · Cited by 39
The Role of Interleukin-17 in Juvenile Idiopathic Arthritis: From Pathogenesis to Treatment
Paroli, M., Spadea, L., Caccavale, R., Spadea, L., Paroli, M. P., & Nante, N. (2022) · Medicina · doi:10.3390/medicina58111552 · Cited by 39
Isolation, Characterization and Functional Examination of the Gingival Immune Cell Network
Dutzan, N., Abusleme, L., Konkel, J. E., & Moutsopoulos, N. M. (2016) · Journal of Visualized Experiments · doi:10.3791/53736 · Cited by 39
Innate lymphoid cells in autoimmunity and chronic inflammatory diseases
Xiong, T., & Turner, J. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0670-4 · Cited by 39
“From a clinical point of view, the blockade of T helper celland ILC-associated cytokines, such as IL-17A and IL-23, has achieved promising results in a variety of chronic inflammatory disorders [86].”
BackgroundGao, J., Cui, J., Zhong, H., Li, Y., Liu, W., Jiao, C., Gao, J., Jiang, C., Guo, W., & Xu, Q. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106426 · Cited by 39
Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis
Theophanous, S., Sargiannidou, I., & Kleopa, K. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179588 · Cited by 38
“They express IL-17A, a pro-inflammatory cytokine involved in the pathogenesis of autoimmune diseases [86], with a subpopulation expressing IL-17 in active lesions [87].”
BackgroundT helper cells in depression: central role of Th17 cells
Ghosh, R., Mitra, P., Kumar, P. V. S. N. K., Goyal, T., & Sharma, P. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2021.1965535 · Cited by 38
Wu, Y., Li, N., Zhang, T., Che, Y., Duan, K., Wang, Y., Zhou, H., Wan, X. H., Lei, H., Nguyen, A. D., et al. (2021) · Poultry Science · doi:10.1016/j.psj.2021.101549 · Cited by 38
Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review
Garcillán, B., Salavert, M., Regueiro, J. R., & Díaz-Castroverde, S. (2022) · Vaccines · doi:10.3390/vaccines10020297 · Cited by 38
Erazo-Martínez, V., Tobón, G. J., & Cañas, C. A. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103262 · Cited by 38
Somers, J., Ruttens, D., Verleden, S. E., Vandermeulen, E., Piloni, D., Wauters, E., Lambrechts, D., Vos, R., Verleden, G. M., Vanaudenaerde, B. M., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.03.009 · Cited by 38
“Although IL-17RA is the most needed for IL-17A binding, optimal IL-17A binding is only accomplished by formation of a productive receptor complex together with IL-17RC.26 The IL-17RA polymorphisms assessed were located on an intron (between exon 12 and 13) (rs2241049) and on exon 13 (rs882643).”
BackgroundHuber, M., & Lohoff, M. D. (2015) · Allergo Journal International · doi:10.1007/s40629-015-0038-4 · Cited by 38
Finley, P. J., DeClue, C. E., Sell, S. A., DeBartolo, J. M., & Shornick, L. P. (2015) · Advances in Wound Care · doi:10.1089/wound.2015.0676 · Cited by 38
“The proinflammatory cytokine, IL-17, is associated with several chronic inflammatory diseases, including psoriasis, rheumatoid arthritis, and multiple sclerosis.(26) Production of IL-17 by CD4 Th17 cells, CD8 T cells, cd T cells, NKT cells, innate lymphoid cells, and neutrophils is important in host defense against pa…”
BackgroundSen, S., He, Z., Ghosh, S., Dery, K. J., Yang, L., Zhang, J., & Sun, Z. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701654 · Cited by 38
“Th17 cells produce effector cytokines IL-17A, IL-17F, IL-22, and GM-CSF to mediate pathological inflammation; targeting Th17 cells is thus a potentially valuable treatment for these diseases (13).”
BackgroundHost response to respiratory syncytial virus infection
Arruvito, L., Raiden, S., & Geffner, J. R. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000159 · Cited by 37
Integrating the pathogenesis of spondyloarthritis: gut and joint united?
Wilde, K. D., Debusschere, K., Beeckman, S., Jacques, P., & Elewaut, D. S. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000144 · Cited by 37
Dey, I., & Bishayi, B. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.10.033 · Cited by 37
Vorobjova, T., Tagoma, A., Oras, A., Alnek, K., Kisand, K., Talja, I., Uibo, O., & Uibo, R. (2019) · Journal of Immunology Research · doi:10.1155/2019/6179243 · Cited by 37
“There is evidence that Th17 cells activated by IL-23 promote chronic tissue inflammation during infection [61] and are associated with protective immunity at the mucosa surface [62].”
BackgroundFu, S., Chien, M., Hsu, C.-Y., Liu, Y., & Sytwu, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093379 · Cited by 37
Brain Immune Interactions—Novel Emerging Options to Treat Acute Ischemic Brain Injury
Muhammad, S., Chaudhry, S. R., Kahlert, U. D., Niemela, M. R., & Hänggi, D. (2021) · Cells · doi:10.3390/cells10092429 · Cited by 38
Making many from few: IL-12p40 as a model for the combinatorial assembly of heterodimeric cytokines
Abdi, K., & Singh, N. J. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.026 · Cited by 37
“T cells that differentiate to become IL-17-producing effectors are involved in immunity to fungal and bacterial pathogens as well as in triggering autoimmune diseases such as psoriasis, arthritis and multiple sclerosis [5].”
BackgroundChorioamnionitis, IL‐17A, and fetal origins of neurologic disease
Lawrence, S. M., & Wynn, J. L. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12803 · Cited by 37
Chen, L., Liu, Y., Yue, S., Wang, H., Chen, J., Ma, W., Xu, W., Xu, M., Chen, Z., Chen, X., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.94704 · Cited by 36
“T helper 17 (Th17) cells, a subpopulation of CD4 + T cells, can secret interleukin (IL)-17A, IL-17F, and IL-22, and Th17 cell-mediated immune response has been proven to participate in autoimmune disease development [22-24].”
BackgroundTan, X., Chen, R., Zhu, S., Wang, H., Yan, D., Zhang, X., Farmakiotis, D., & Mylonakis, E. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02180-15 · Cited by 36
“Since the gene for IL-26 is absent in rodents (21, 22), other mechanisms are likely implicated in our rat model observations, and it is not known whether they are conserved in humans, as well.”
BackgroundYoshida, S., Shime, H., Funami, K., Takaki, H., Matsumoto, M., Kasahara, M., & Seya, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169360 · Cited by 36
The human IL ‐17A/F heterodimer regulates psoriasis‐associated genes through IκBζ
Bertelsen, T., Iversen, L., & Johansen, C. (2018) · Experimental Dermatology · doi:10.1111/exd.13722 · Cited by 36
Catar, R. A., Chen, L., Cuff, S. M., Kift-Morgan, A. P., Eberl, M., Kettritz, R., Kamhieh‐Milz, J., Moll, G., Li, Q., Zhao, H., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5438 · Cited by 36
“However, the involvement of other transcription factors is also possible [15].”
BackgroundInfluentialSystematic analysis of the IL ‐17 receptor signalosome reveals a robust regulatory feedback loop
Draberova, H., Janusova, S., Knizkova, D., Semberova, T., Pribikova, M., Ujevic, A., Harant, K., Knapkova, S., Hrdinka, M., Fanfani, V., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104202 · Cited by 35
“Perhaps, this is why this study is either ignored or misinterpreted in a number of recent reviews on the topic of IL-17 signaling (Gaffen et al , 2014; Monin & Gaffen, 2018; Li et al , 2019; McGeachy et al , 2019; Swaidani et al , 2019).”
IL-23 Enhances C-Fiber-Mediated and Blue Light-Induced Spontaneous Pain in Female Mice
Ji, J., He, Q., Luo, X., Bang, S., Matsuoka, Y., McGinnis, A., Nackley, A. G., & Ji, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.787565 · Cited by 36
Therapeutic potential of targeting IL-17 and its receptor signaling in neuroinflammation
Gautam, A. S., & Singh, R. K. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103517 · Cited by 36
Saeed, M. A., Ng, G. Z., Däbritz, J., Wagner, J., Judd, L. M., Han, J.-X., Dhar, P., Kirkwood, C. D., & SUTTON, P. R. N. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001045 · Cited by 37
Liu, Y., Cui, X., Wang, S., Liu, J., Zhao, N., Huang, M., Qin, J., Li, Y., Shan, Z., & Teng, W. (2020) · Thyroid · doi:10.1089/thy.2019.0552 · Cited by 36
“Activation of STAT3 is a key event in Th17 lineage specification (11).”
Pulmonary fibrosis and type-17 immunity
Senoo, S., Higo, H., Taniguchi, A., Kiura, K., Maeda, Y., & Miyahara, N. (2023) · Respiratory Investigation · doi:10.1016/j.resinv.2023.05.005 · Cited by 35
Khera, A., Kanta, P., Kalra, J. K., Dumir, D., & Thungapathra, M. (2018) · Journal of Women & Aging · doi:10.1080/08952841.2018.1522126 · Cited by 35
Su, Z., Paulsboe, S. E., Wetter, J. B., Salte, K. M., Kannan, A., Mathew, S., Horowitz, A., Gerstein, C., Namovic, M. T., Todorović, V., et al. (2018) · Experimental Dermatology · doi:10.1111/exd.13841 · Cited by 35
Lebwohl, M., Gordon, K. B., Gallo, G., Zhang, L., & Paul, C. F. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15921 · Cited by 35
Motavalli, R., Etemadi, J., Kahroba, H., Mehdizadeh, A., & Yousefi, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116923 · Cited by 37
Sun, R., & Abraham, C. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.05.007 · Cited by 35
“Studies examining responses to IL23 through IL23R have focused on IL17-producing cells such as Th17 cells, innate lymphoid cells, and natural killer (NK) cells.(1,2,10) Similarly, primary human cell studies focusing on the effects of the IBD-protective IL23R–R381Q variant primarily have examined T cells, where this va…”
BackgroundNarjes, F., Llinàs, A., von Berg, S., Jirholt, J., Lever, S. R., Pehrson, R., Collins, M., Malmberg, A., Svanberg, P., Xue, Y., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01197 · Cited by 35
IL-17A–Producing γδ T Cells Suppress Early Control of Parasite Growth by Monocytes in the Liver
Sheel, M., Beattie, L., Frame, T. C. M., Rivera, F. D. L., Faleiro, R. J., Bunn, P. T., de, M. M., Edwards, C. L., Ng, S. S., Kumar, R., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501046 · Cited by 35
“Similarly, factors such as dectins, TLRs, IL-1, and IL23 (1) that stimulate the activation of gd T cells and the downstream effector functions of gd T cells once they are activated, including cytokine and chemokine production, interactions with B cells, ab T cells, and cytotoxicity (54), are all areas of interest and…”
BackgroundSharma, N., & Toor, D. (2016) · Cytokine · doi:10.1016/j.cyto.2016.11.010 · Cited by 35
Diani, M., Galasso, M., Cozzi, C., Sgambelluri, F., Altomare, A., Cigni, C., Frigerio, E., Drago, L., Volinia, S., Granucci, F., et al. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.04.001 · Cited by 35
miR-340 Alleviates Psoriasis in Mice through Direct Targeting of IL-17A
Bian, J., Liu, R., Fan, T., Liao, L., Wang, S., Geng, W., Wang, T., Shi, W., & Ruan, Q. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800189 · Cited by 35
“T he Th17 cell is a new lineage of CD4 effector Th cells that play important roles in immune regulation, host defense, and the pathogenesis of autoimmune and other chronic inflammatory disorders (1, 2).”
BackgroundBorbón, T. Y., Scorza, B. M., Clay, G. M., de Queiroz, F. L. N., Sariol, A., Bowen, J. L., Chen, Y., Zhanbolat, B., Parlet, C. P., Valadares, D. G., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007247 · Cited by 35
“Additionally, IL-6 and particularly IL-23 are important for the differentiation and maintenance of Th17 cells [51, 52].”
BackgroundKhatri, A., Eckert, D., Oberoi, R. K., Suleiman, A. A., Pang, Y., Cheng, L., & Othman, A. A. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1473 · Cited by 35
Zhu, Y., Ma, Y., Zu, W., Song, J., Wang, H., Zhong, Y. J., Li, H., Zhang, Y., Gao, Q., Kong, B., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00055 · Cited by 35
Long, F., Wei, X., Chen, Y., Li, M., Lian, N., Yu, S., Chen, S., Yang, Y., Li, M., Gu, H., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06545-5 · Cited by 34
“Non-pyroptotic cleavage fragment of GSDMD was reported to regulate gene expression.”
BackgroundFan, T., Tai, C., Sleiman, K. C., Cutcliffe, M. P., Kim, H., Liu, Y., Li, J., Xin, G., Grashel, M., Baert, L., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02125-7 · Cited by 34
Gabrion, A., Hmitou, I., Moshous, D., Neven, B., Lefèvre‐Utile, A., Diana, J., Suárez, F., Pïcard, C., Blanche, S., Fischer, A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.033 · Cited by 34
Ergen, E. N., & Yusuf, N. (2018) · Experimental Dermatology · doi:10.1111/exd.13676 · Cited by 34
Yang, P., Zhang, M., Wang, X., Xu, A.-L., Shen, M., Jiang, B., Zhou, X., & Zhou, L. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113822 · Cited by 34
Tahamtan, A., Besteman, S. B., Samadizadeh, S., Rastegar, M., Bont, L., & Salimi, V. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15318 · Cited by 34
Lack of evidence for expression and function of IL-39 in human immune cells
Ecoeur, F., Weiss, J., Schleeger, S., & Guntermann, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242329 · Cited by 34
Metadata
- Authors
- Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Cua, Daniel J.
- Venue
- Nature reviews. Immunology
- Published
- 2014-08-22
- Volume
- 14
- Issue
- 9
- Pages
- 585-600
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC4281037
- OpenAlex
- W2064645845
- Cited by
- 1,585
- References
- 187
- Citations by year
- 2026: 119 · 2025: 104 · 2024: 111 · 2023: 126 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 131 · 2018: 153 · 2017: 155 · 2016: 129 · 2015: 111 · 2014: 6
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI107825, AI107825)
- National Institute of Dental and Craniofacial Research (R01DE022550, R01DE023815, DE022550)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-23, IL-17, Th17 cells, T cell lineage commitment, transcriptional regulation, IL-17 signaling, mesenchyme, immune-mediated inflammatory diseases, therapeutic antibodies
- MeSH terms
- Antibodies, Autoimmune Diseases, Epithelial Cells, Humans, Transcription, Genetic, Signal Transduction, Cytokines, Tight Junctions, Interleukin-17, Receptors, Interleukin-17, Interleukin-23, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.